Mucosal immunology and probiotics

Antonio Cascio, Valeria Rizzello, Maria Luisa Dongarrà, Letizia Muccio, Guido Ferlazzo, Irene Bonaccorsi, Antonio Cascio, Walter Fries

Risultato della ricerca: Article

61 Citazioni (Scopus)

Abstract

The cross-talk between the mucosa-associated immune system and microbiota is critical in mucosal tissue homeostasis as well as in protection against infectious and inflammatory diseases occurring at mucosal sites. This recent evidence has paved the way to therapeutic approaches aimed at modulating the mucosa-associated immune system using probiotics. Different strains of probiotics possess the ability to finely regulate dendritic cell (DC) activation, polarizing the subsequent T cell activity toward Th1 (e.g. Lactobacillus (Lb) acidophilus), Th2 (Lb.reuteri and Bifidobacterium bifidum) or, as more recently demonstrated, Th17 responses induced by specific strains such as Lb.rhamnosus GG and Lac23a, the latter isolated in our laboratory. Here, we review some recent advances in our understanding of probiotics effects on mucosal immunology, particularly on cells of the innate immunity such as DCs. We also highlight our own experiences in modulating DC functions by commensal bacteria and discuss the relevance of probiotics administration in the treatment of human immunopathologies. © 2012 Springer Science+Business Media New York.
Lingua originaleEnglish
pagine (da-a)19-26
Numero di pagine8
RivistaCURRENT ALLERGY AND ASTHMA REPORTS
Volume13
Stato di pubblicazionePublished - 2013

Fingerprint

Probiotics
Allergy and Immunology
Lactobacillus rhamnosus
Mucous Membrane
Dendritic Cells
Immune System
Lactobacillus reuteri
Lactobacillus acidophilus
Microbiota
Innate Immunity
Communicable Diseases
Homeostasis
Bacteria
T-Lymphocytes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cita questo

Cascio, A., Rizzello, V., Dongarrà, M. L., Muccio, L., Ferlazzo, G., Bonaccorsi, I., ... Fries, W. (2013). Mucosal immunology and probiotics. CURRENT ALLERGY AND ASTHMA REPORTS, 13, 19-26.

Mucosal immunology and probiotics. / Cascio, Antonio; Rizzello, Valeria; Dongarrà, Maria Luisa; Muccio, Letizia; Ferlazzo, Guido; Bonaccorsi, Irene; Cascio, Antonio; Fries, Walter.

In: CURRENT ALLERGY AND ASTHMA REPORTS, Vol. 13, 2013, pag. 19-26.

Risultato della ricerca: Article

Cascio, A, Rizzello, V, Dongarrà, ML, Muccio, L, Ferlazzo, G, Bonaccorsi, I, Cascio, A & Fries, W 2013, 'Mucosal immunology and probiotics', CURRENT ALLERGY AND ASTHMA REPORTS, vol. 13, pagg. 19-26.
Cascio A, Rizzello V, Dongarrà ML, Muccio L, Ferlazzo G, Bonaccorsi I e altri. Mucosal immunology and probiotics. CURRENT ALLERGY AND ASTHMA REPORTS. 2013;13:19-26.
Cascio, Antonio ; Rizzello, Valeria ; Dongarrà, Maria Luisa ; Muccio, Letizia ; Ferlazzo, Guido ; Bonaccorsi, Irene ; Cascio, Antonio ; Fries, Walter. / Mucosal immunology and probiotics. In: CURRENT ALLERGY AND ASTHMA REPORTS. 2013 ; Vol. 13. pagg. 19-26.
@article{732f20520faa4092848fcf53293657cb,
title = "Mucosal immunology and probiotics",
abstract = "The cross-talk between the mucosa-associated immune system and microbiota is critical in mucosal tissue homeostasis as well as in protection against infectious and inflammatory diseases occurring at mucosal sites. This recent evidence has paved the way to therapeutic approaches aimed at modulating the mucosa-associated immune system using probiotics. Different strains of probiotics possess the ability to finely regulate dendritic cell (DC) activation, polarizing the subsequent T cell activity toward Th1 (e.g. Lactobacillus (Lb) acidophilus), Th2 (Lb.reuteri and Bifidobacterium bifidum) or, as more recently demonstrated, Th17 responses induced by specific strains such as Lb.rhamnosus GG and Lac23a, the latter isolated in our laboratory. Here, we review some recent advances in our understanding of probiotics effects on mucosal immunology, particularly on cells of the innate immunity such as DCs. We also highlight our own experiences in modulating DC functions by commensal bacteria and discuss the relevance of probiotics administration in the treatment of human immunopathologies. {\circledC} 2012 Springer Science+Business Media New York.",
keywords = "Allergy; Autoimmunity; Bifidobacteria; Commensal bacteria; Crohn's disease; Dendritic cells; GALT; IEC; Immune-mediated diseases; Immunopathology; Immunotherapy; Inflammatory bowel diseases; Interleukins; LAB; Lactobacilli; MALT; Microbiota; Mucosal immunology; PAMP; Probiotics; PRR; T- cell polarization; Th1; Th17; Th2; TLRs; Ulcerative colitis; Animals; Bifidobacterium; Dendritic Cells; Humans; Immune System; Immunity, Innate; Immunity, Mucosal; Lactobacillus; Mucous Membrane; Probiotics; Immunology and Allergy; Pulmonary and Respiratory Medicine",
author = "Antonio Cascio and Valeria Rizzello and Dongarr{\`a}, {Maria Luisa} and Letizia Muccio and Guido Ferlazzo and Irene Bonaccorsi and Antonio Cascio and Walter Fries",
year = "2013",
language = "English",
volume = "13",
pages = "19--26",
journal = "CURRENT ALLERGY AND ASTHMA REPORTS",
issn = "1529-7322",

}

TY - JOUR

T1 - Mucosal immunology and probiotics

AU - Cascio, Antonio

AU - Rizzello, Valeria

AU - Dongarrà, Maria Luisa

AU - Muccio, Letizia

AU - Ferlazzo, Guido

AU - Bonaccorsi, Irene

AU - Cascio, Antonio

AU - Fries, Walter

PY - 2013

Y1 - 2013

N2 - The cross-talk between the mucosa-associated immune system and microbiota is critical in mucosal tissue homeostasis as well as in protection against infectious and inflammatory diseases occurring at mucosal sites. This recent evidence has paved the way to therapeutic approaches aimed at modulating the mucosa-associated immune system using probiotics. Different strains of probiotics possess the ability to finely regulate dendritic cell (DC) activation, polarizing the subsequent T cell activity toward Th1 (e.g. Lactobacillus (Lb) acidophilus), Th2 (Lb.reuteri and Bifidobacterium bifidum) or, as more recently demonstrated, Th17 responses induced by specific strains such as Lb.rhamnosus GG and Lac23a, the latter isolated in our laboratory. Here, we review some recent advances in our understanding of probiotics effects on mucosal immunology, particularly on cells of the innate immunity such as DCs. We also highlight our own experiences in modulating DC functions by commensal bacteria and discuss the relevance of probiotics administration in the treatment of human immunopathologies. © 2012 Springer Science+Business Media New York.

AB - The cross-talk between the mucosa-associated immune system and microbiota is critical in mucosal tissue homeostasis as well as in protection against infectious and inflammatory diseases occurring at mucosal sites. This recent evidence has paved the way to therapeutic approaches aimed at modulating the mucosa-associated immune system using probiotics. Different strains of probiotics possess the ability to finely regulate dendritic cell (DC) activation, polarizing the subsequent T cell activity toward Th1 (e.g. Lactobacillus (Lb) acidophilus), Th2 (Lb.reuteri and Bifidobacterium bifidum) or, as more recently demonstrated, Th17 responses induced by specific strains such as Lb.rhamnosus GG and Lac23a, the latter isolated in our laboratory. Here, we review some recent advances in our understanding of probiotics effects on mucosal immunology, particularly on cells of the innate immunity such as DCs. We also highlight our own experiences in modulating DC functions by commensal bacteria and discuss the relevance of probiotics administration in the treatment of human immunopathologies. © 2012 Springer Science+Business Media New York.

KW - Allergy; Autoimmunity; Bifidobacteria; Commensal bacteria; Crohn's disease; Dendritic cells; GALT; IEC; Immune-mediated diseases; Immunopathology; Immunotherapy; Inflammatory bowel diseases; Interleukins; LAB; Lactobacilli; MALT; Microbiota; Mucosal immun

KW - Innate; Immunity

KW - Mucosal; Lactobacillus; Mucous Membrane; Probiotics; Immunology and Allergy; Pulmonary and Respiratory Medicine

UR - http://hdl.handle.net/10447/160256

M3 - Article

VL - 13

SP - 19

EP - 26

JO - CURRENT ALLERGY AND ASTHMA REPORTS

JF - CURRENT ALLERGY AND ASTHMA REPORTS

SN - 1529-7322

ER -